Frequently Asked Questions about Zimmer Biomet Holdings, Inc. (ZBH)

Name: Zimmer Biomet Holdings, Inc. (ZBH) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Zimmer Biomet Holdings, Inc. (ZBH) do?

Accepted Answer

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products;...

Question 2

Is Zimmer Biomet Holdings, Inc. (ZBH) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of ZBH reveals an Altman Z-Score of 1.70 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($8.23B most recent), help investors decide if ZBH fits their risk profile.

Question 3

What is the current P/E ratio for ZBH?

Accepted Answer

As of the latest trading session, Zimmer Biomet Holdings, Inc. (ZBH) has a trailing P/E ratio of 25.56.

Question 4

Who is the CEO of Zimmer Biomet Holdings, Inc.?

Accepted Answer

The current Chief Executive Officer of Zimmer Biomet Holdings, Inc. is Ivan Tornos.

Question 5

What was ZBH's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Zimmer Biomet Holdings, Inc. reported annual revenues of $8.23B (2025), $7.68B (2024), $7.39B (2023), $6.94B (2022), $6.83B (2021) respectively.

Question 6

Does ZBH pay a dividend?

Accepted Answer

Zimmer Biomet Holdings, Inc. currently pays a dividend to its shareholders, with a trailing dividend yield of 1.05%.

Question 7

How much debt and cash flow does ZBH have?

Accepted Answer

In its latest reporting period, Zimmer Biomet Holdings, Inc. generated $1.47B in Free Cash Flow against a total debt load of $7.52B.

Question 8

What is the Price-to-Book (P/B) ratio of Zimmer Biomet Holdings, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Zimmer Biomet Holdings, Inc. (ZBH) is currently 1.42.

Question 9

What is the Price-to-Sales (P/S) ratio of ZBH?

Accepted Answer

Based on trailing twelve-month data, Zimmer Biomet Holdings, Inc. (ZBH) trades at a Price-to-Sales (P/S) ratio of 2.20.

Question 10

What is Zimmer Biomet Holdings, Inc.'s Return on Equity (ROE)?

Accepted Answer

Zimmer Biomet Holdings, Inc. (ZBH) has a Return on Equity (ROE) of 5.60%, representing its profitability relative to shareholder equity.

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	8.2B	5.1B	1.4B	705.2M	3.56
2024-12	7.7B	5.5B	1.3B	903.8M	4.45
2023-12	7.4B	5.3B	1.3B	1B	4.91
2022-12	6.9B	4.9B	696.3M	231.4M	1.10
2021-12	6.8B	4.9B	860.3M	401.6M	1.93

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	8.2B	5.1B	1.4B	705.2M	3.56
2024-12	7.7B	5.5B	1.3B	903.8M	4.45
2023-12	7.4B	5.3B	1.3B	1B	4.91
2022-12	6.9B	4.9B	696.3M	231.4M	1.10
2021-12	6.8B	4.9B	860.3M	401.6M	1.93